Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1377365 | Bioorganic & Medicinal Chemistry Letters | 2008 | 5 Pages |
Abstract
N-3-(Phenylcarbamoyl)arylpyrimidine-5-carboxamides are a novel class of selective Lck inhibitors. This series of compounds derives its selectivity from a hydrogen bond with the gatekeeper Thr316 of the enzyme. X-ray co-crystal structural data, structure–activity relationships, and the synthesis of these inhibitors are reported herein.
Graphical abstractA novel class of selective Lck inhibitors is reported. X-ray co-crystal structural data, structure–activity relationships, and the synthesis of these inhibitors are described.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Holly L. Deak, John R. Newcomb, Joseph J. Nunes, Christina Boucher, Alan C. Cheng, Erin F. DiMauro, Linda F. Epstein, Paul Gallant, Brian L. Hodous, Xin Huang, Josie H. Lee, Vinod F. Patel, Stephen Schneider, Susan M. Turci, Xiaotian Zhu,